keyword
https://read.qxmd.com/read/38179739/glun2a-mediates-ps-induced-depressive-like-behavior-by-activating-camkii-and-inhibiting-myelinization
#21
JOURNAL ARTICLE
Huimei Huang, Hongli Jiang, Hongli Sun
BACKGROUND: Prenatal stress (PS) can induce depression in offspring, but the underlying mechanisms are still unknown. OBJECTIVE: The aim of this work was to investigate the mechanism that underlies PS-induced depressive-like behavior in offspring. METHODS: A prenatal restraint stress procedure was developed in which pregnant rats at GD14 to GD20 were placed head-first into a well-ventilated bottle three times each day and for 45 min each time...
December 26, 2023: Frontiers in Bioscience (Landmark Edition)
https://read.qxmd.com/read/38136657/role-of-nmda-receptor-in-high-pressure-neurological-syndrome-and-hyperbaric-oxygen-toxicity
#22
REVIEW
Alice Bliznyuk, Yoram Grossman
Professional divers exposed to pressures greater than 11 ATA (1.1 MPa) may suffer from high-pressure neurological syndrome (HPNS). Divers who use closed-circuit breathing apparatus and patients and medical attendants undergoing hyperbaric oxygen therapy (HBOT) face the risk of CNS hyperbaric oxygen toxicity (HBOTx) at oxygen pressure above 2 ATA (0.2 MPa). Both syndromes are characterized by reversible CNS hyperexcitability, accompanied by cognitive and motor deficits, and N-methyl-D-aspartate receptor (NMDAR) plays a crucial role in provoking them...
December 13, 2023: Biomolecules
https://read.qxmd.com/read/38114151/-effect-of-suanzaoren-decoction-on-expression-of-ionotropic-glutamate-receptors-and-synaptic-plasticity-in-hippocampus-of-anxiety-rats
#23
JOURNAL ARTICLE
Hong-Kun Wang, Jin-Ming He, Yue-Heng Yan, Zi-Hao Wang, Ruo-Xuan Li, Yan-Yan Wang
This study investigated the effect of Suanzaoren Decoction on the expression of N-methyl-D-aspartate receptors(NMDAR) and α-amino-3-hydroxy-5-methyl-4-isoxazole-propionic acid receptors(AMPAR) in the hippocampus and synaptic plasticity in rats with conditioned fear-induced anxiety. The effect of Suanzaoren Decoction on rat behaviors were evaluated through open field experiment, elevated plus maze experiment, and light/dark box experiment. Enzyme-linked immunosorbent assay(ELISA) was used to measure the levels of glutamate(Glu) and γ-aminobutyric acid(GABA) in the rat hippocampus...
October 2023: Zhongguo Zhong Yao za Zhi, Zhongguo Zhongyao Zazhi, China Journal of Chinese Materia Medica
https://read.qxmd.com/read/38093836/therapeutic-potential-of-kaempferol-against-sleep-deprivation-induced-cognitive-impairment-modulation-of-neuroinflammation-and-synaptic-plasticity-disruption-in-mice
#24
JOURNAL ARTICLE
Ya-Ya Du, Ting Sun, Qi Yang, Qing-Qing Liu, Jia-Min Li, Le Yang, Lan-Xin Luo
Sleep deprivation (SD) has led to a rise in cognitive impairment (CI) cases. Kaempferol (KMP), known for its anti-inflammatory and antiapoptotic properties, holds promise in countering SD-induced CI. Experimental validation using a sleep-deprived CI model confirmed KMP's efficacy in mitigating CI. Immunofluorescence investigations emphasized diminished activation of astrocytes and reduced the proliferation of microglia in the hippocampus of mice subjected to SD. Subsequently, network pharmacological analyses were conducted and found that KMP may be closely related to the mitogen-activated protein kinase (MAPK) pathway in SD-induced CI...
December 8, 2023: ACS Pharmacology & Translational Science
https://read.qxmd.com/read/38050135/a-frameshift-variant-of-glun2a-identified-in-an-epilepsy-patient-results-in-nmda-receptor-mistargeting
#25
JOURNAL ARTICLE
M M Vieira, S Peng, S Won, E Hong, S K Inati, A Thurm, A H Thiam, S Kim, S J Myers, J D Badger, S F Traynelis, W Lu, K W Roche
N-methyl-D-aspartate receptors (NMDARs) are crucial for neuronal development and synaptic plasticity. Dysfunction of NMDARs is associated with multiple neurodevelopmental disorders, including epilepsy, autism spectrum disorder, and intellectual disability. Understanding the impact of genetic variants of NMDAR subunits can shed light on the mechanisms of disease. Here, we characterized the functional implications of a de novo mutation of the GluN2A subunit (P1199Rfs*32) resulting in the truncation of the C-terminal domain (CTD)...
November 30, 2023: Journal of Neuroscience
https://read.qxmd.com/read/38037434/reduced-expression-of-glun2a-induces-a-delay-in-neuron-maturation
#26
JOURNAL ARTICLE
María Florencia Acutain, María Verónica Baez
NMDA receptors (NMDARs) play an important role in synaptic plasticity both in physiological and pathological conditions. GluN2A and GluN2B are the most expressed NMDAR regulatory subunits, in the hippocampus and other cognitive-related brain structures. GluN2B is characteristic of immature structures and GluN2A of mature ones. Changes in GluN2A expression were associated with complex phenotypes that led to complex neurodevelopmental disorders, including the occurrence of seizures. However, little is known about the role of GluN2A in these phenotypes...
November 30, 2023: Journal of Neurochemistry
https://read.qxmd.com/read/38015765/the-glun2b-containing-nmda-receptor-alleviates-neuronal-apoptosis-in-neonatal-hypoxic-ischemic-encephalopathy-by-activating-pi3k-akt-creb-signaling-pathwa
#27
JOURNAL ARTICLE
X Zhang, K-Z Peng, S-L Xu, M-X Wu, H-J Sun, J Zhao, S Yang, S-J Liu, C-Y Lia, X-M Zhang
Neonatal hypoxic-ischemic encephalopathy (HIE) is a disease caused by insufficient blood supply in the brain in newborns during the perinatal period. Severe HIE leads to patient death, and patients with mild HIE are at increased risk of cognitive deficits and behavioral abnormalities. The NMDA receptor is an important excitatory receptor in the central nervous system, and in adult hypoxic-ischemic injury both subtypes of the NMDA receptor play important but distinct roles. The GluN2A-containing NMDA receptor (GluN2A-NMDAR) could activate neuronal protective signaling pathway, while the GluN2B-NMDAR subtype is coupled to the apoptosis-inducing signaling pathway and leads to neuronal death...
November 28, 2023: Physiological Research
https://read.qxmd.com/read/38004401/glun2a-and-glun2b-n-methyl-d-aspartate-receptor-nmdars-subunits-their-roles-and-therapeutic-antagonists-in-neurological-diseases
#28
REVIEW
Amany Digal Ladagu, Funmilayo Eniola Olopade, Adeboye Adejare, James Olukayode Olopade
N-methyl-D-aspartate receptors (NMDARs) are ion channels that respond to the neurotransmitter glutamate, playing a crucial role in the permeability of calcium ions and excitatory neurotransmission in the central nervous system (CNS). Composed of various subunits, NMDARs are predominantly formed by two obligatory GluN1 subunits (with eight splice variants) along with regulatory subunits GluN2 (GluN2A-2D) and GluN3 (GluN3A-B). They are widely distributed throughout the CNS and are involved in essential functions such as synaptic transmission, learning, memory, plasticity, and excitotoxicity...
October 30, 2023: Pharmaceuticals
https://read.qxmd.com/read/37989792/stim2-regulates-nmda-receptor-endocytosis-that-is-induced-by-short-term-nmda-receptor-overactivation-in-cortical-neurons
#29
JOURNAL ARTICLE
Karolina Serwach, Ewa Nurowska, Marta Klukowska, Barbara Zablocka, Joanna Gruszczynska-Biegala
Recent findings suggest an important role for the dysregulation of stromal interaction molecule (STIM) proteins, activators of store-operated Ca2+ channels, and the prolonged activation of N-methyl-D-aspartate receptors (NMDARs) in the development of neurodegenerative diseases. We previously demonstrated that STIM silencing increases Ca2+ influx through NMDAR and STIM-NMDAR2 complexes are present in neurons. However, the interplay between NMDAR subunits (GluN1, GluN2A, and GluN2B) and STIM1/STIM2 with regard to intracellular trafficking remains unknown...
November 21, 2023: Cellular and Molecular Life Sciences: CMLS
https://read.qxmd.com/read/37947603/prenatal-cannabinoid-exposure-elicits-memory-deficits-associated-with-reduced-psa-ncam-expression-altered-glutamatergic-signaling-and-adaptations-in-hippocampal-synaptic-plasticity
#30
JOURNAL ARTICLE
Priyanka D Pinky, Jenna Bloemer, Warren D Smith, Yifeng Du, Ryan T Heslin, Sharay E Setti, Jeremiah C Pfitzer, Kawsar Chowdhury, Hao Hong, Subhrajit Bhattacharya, Muralikrishnan Dhanasekaran, Alexander Dityatev, Miranda N Reed, Vishnu Suppiramaniam
Cannabis is now one of the most commonly used illicit substances among pregnant women. This is particularly concerning since developmental exposure to cannabinoids can elicit enduring neurofunctional and cognitive alterations. This study investigates the mechanisms of learning and memory deficits resulting from prenatal cannabinoid exposure (PCE) in adolescent offspring. The synthetic cannabinoid agonist WIN55,212-2 was administered to pregnant rats, and a series of behavioral, electrophysiological, and immunochemical studies were performed to identify potential mechanisms of memory deficits in the adolescent offspring...
October 26, 2023: Cells
https://read.qxmd.com/read/37913985/intranasal-oxytocin-alleviates-comorbid-depressive-symptoms-in-neuropathic-pain-via-elevating-hippocampal-bdnf-production-in-both-female-and-male-mice
#31
JOURNAL ARTICLE
Rongjun Liu, Daofan Sun, Xiuzhong Xing, Qingge Chen, Bo Lu, Bo Meng, Hui Yuan, Lan Mo, Liufang Sheng, Jinwei Zheng, Qiusheng Wang, Junping Chen, Xiaowei Chen
The comorbidity of pain and depression is frequently observed in patients suffering from chronic pain and depression. However, the comorbid mechanism is not well elucidated and the therapeutic medication is still inadequate. Oxytocin is a neuropeptide synthesized in the hypothalamus. It has been reported to relieve chronic pain and depressive symptoms. However, the analgesic action and mechanisms of oxytocin have mainly been investigated using peripheral or spinal administration. Because of the advantage of intranasal delivery of oxytocin in crossing the blood-brain barrier, we investigated the effect of intranasal application of oxytocin on neuropathic pain and comorbid depressive symptoms in both female and male mice...
October 30, 2023: Neuropharmacology
https://read.qxmd.com/read/37913973/hippocampal-circank3-deficiency-causes-anxiety-like-behaviors-and-social-deficits-by-regulating-the-mir-7080-3p-iqgap1-pathway-in-mice
#32
JOURNAL ARTICLE
Yuman He, Linhong Jiang, Haxiaoyu Liu, Qian Bu, Weihong Kuang, Ying Zhao, Yaxing Chen, Ni Zhang, Yuzhou Xiao, Shu Li, Rong Chen, Shuang Han, Yuanyi Zhou, Jiamei Zhang, Xuemei Wan, Rui Xu, Shaomin Wang, Haoluo Zhang, Hui Gu, Qingfan Wei, Feng Qin, Yue Zhao, Hongchun Li, Liang Wang, Xiaojie Wang, Yonghai Wang, Yanping Dai, Min Li, Yuanyuan Chen, Hongbo Wang, Jingwei Tian, Yinglan Zhao, Xiaobo Cen
BACKGROUND: Circular RNAs (circRNAs) are highly enriched in the synapses of the mammalian brain and play important roles in neurological function by acting as molecular sponges of microRNAs (miRNAs). CircAnk3 is derived from the 11th intron of the Ankyrin 3 (Ank3) gene, a strong genetic risk factor for neuropsychiatric disorders; however, the function of circAnk3 remains elusive. In this study, we investigated the function of circAnk3 and its downstream regulatory network for target genes in the hippocampus of mice...
October 30, 2023: Biological Psychiatry
https://read.qxmd.com/read/37876813/distinct-effects-of-ampar-subunit-depletion-on-spatial-memory
#33
JOURNAL ARTICLE
Ahmed Eltokhi, Ilaria Bertocchi, Andrei Rozov, Vidar Jensen, Thilo Borchardt, Amy Taylor, Catia C Proenca, John Nick P Rawlins, David M Bannerman, Rolf Sprengel
Pharmacological studies established a role for AMPARs in the mammalian forebrain in spatial memory performance. Here we generated global GluA1/3 double knockout mice ( Gria1/3 -/- ) and conditional knockouts lacking GluA1 and GluA3 AMPAR subunits specifically from principal cells across the forebrain ( Gria1/3 ΔFb ). In both models, loss of GluA1 and GluA3 resulted in reduced hippocampal GluA2 and increased levels of the NMDAR subunit GluN2A. Electrically-evoked AMPAR-mediated EPSPs were greatly diminished, and there was an absence of tetanus-induced LTP...
November 17, 2023: IScience
https://read.qxmd.com/read/37803141/adapting-the-endoplasmic-reticulum-proteostasis-rescues-epilepsy-associated-nmda-receptor-variants
#34
JOURNAL ARTICLE
Pei-Pei Zhang, Taylor M Benske, Lucie Y Ahn, Ashleigh E Schaffer, James C Paton, Adrienne W Paton, Ting-Wei Mu, Ya-Juan Wang
The GRIN genes encoding N-methyl-D-aspartate receptor (NMDAR) subunits are remarkably intolerant to variation. Many pathogenic NMDAR variants result in their protein misfolding, inefficient assembly, reduced surface expression, and impaired function on neuronal membrane, causing neurological disorders including epilepsy and intellectual disability. Here, we investigated the proteostasis maintenance of NMDARs containing epilepsy-associated variations in the GluN2A subunit, including M705V and A727T. In the transfected HEK293T cells, we showed that the two variants were targeted to the proteasome for degradation and had reduced functional surface expression...
October 6, 2023: Acta Pharmacologica Sinica
https://read.qxmd.com/read/37768458/the-role-of-nmda-receptor-subunits-in-the-effect-of-memantine-on-the-brain-of-healthy-animals
#35
JOURNAL ARTICLE
V I Arkhipov, I Yu Chernomorets, N S Zhuikova, D A Fedorov, E V Pershina
The non-competitive NMDA glutamate receptor antagonist memantine has neuroprotective properties and is the first non-cholinergic drug approved for the treatment of Alzheimer's disease. The purpose of this work was to test the hypothesis that injections of memantine to healthy animals can affect the subunit composition of NMDA receptors in the brain, which may explain the effects of its chronic administration. For this, the expression of subunits GluN1, GluN2A, GluN2B, and GluN2C was studied in the hippocampus and prefrontal cortex of rats after single or five subchronic injections of memantine...
September 28, 2023: Bulletin of Experimental Biology and Medicine
https://read.qxmd.com/read/37736757/grin2a-nr2a-a-gene-contributing-to-glutamatergic-involvement-in-schizophrenia
#36
REVIEW
Paul J Harrison, David M Bannerman
Involvement of the glutamate system, particularly N-methyl-D-aspartate (NMDA) receptor hypofunction, has long been postulated to be part of the pathophysiology of schizophrenia. An important development is provided by recent data that strongly implicate GRIN2A, the gene encoding the NR2A (GluN2A) NMDA receptor subunit, in the aetiology of the disorder. Rare variants and common variants are both robustly associated with genetic risk for schizophrenia. Some of the rare variants are point mutations likely affecting channel function, but most are predicted to cause protein truncation and thence result, like the common variants, in reduced gene expression...
September 22, 2023: Molecular Psychiatry
https://read.qxmd.com/read/37723282/loss-of-grin2a-causes-a-transient-delay-in-the-electrophysiological-maturation-of-hippocampal-parvalbumin-interneurons
#37
JOURNAL ARTICLE
Chad R Camp, Anna Vlachos, Chiara Klöckner, Ilona Krey, Tue G Banke, Nima Shariatzadeh, Sarah M Ruggiero, Peter Galer, Kristen L Park, Adam Caccavano, Sarah Kimmel, Xiaoqing Yuan, Hongjie Yuan, Ingo Helbig, Tim A Benke, Johannes R Lemke, Kenneth A Pelkey, Chris J McBain, Stephen F Traynelis
N-methyl-D-aspartate receptors (NMDARs) are ligand-gated ionotropic glutamate receptors that mediate a calcium-permeable component to fast excitatory neurotransmission. NMDARs are heterotetrameric assemblies of two obligate GluN1 subunits (GRIN1) and two GluN2 subunits (GRIN2A-GRIN2D). Sequencing data shows that 43% (297/679) of all currently known NMDAR disease-associated genetic variants are within the GRIN2A gene, which encodes the GluN2A subunit. Here, we show that unlike missense GRIN2A variants, individuals affected with disease-associated null GRIN2A variants demonstrate a transient period of seizure susceptibility that begins during infancy and diminishes near adolescence...
September 19, 2023: Communications Biology
https://read.qxmd.com/read/37711124/chronic-lithium-treatment-alters-nmda-and-ampa-receptor-synaptic-availability-and-dendritic-spine-organization-in-the-rat-hippocampus
#38
JOURNAL ARTICLE
Lucia Caffino, Giorgia Targa, Anne Stephanie Mallien, Francesca Mottarlini, Beatrice Rizzi, Judith R Homberg, Peter Gass, Fabio Fumagalli
BACKGROUND: The mechanisms underlying the action of lithium (LiCl) in bipolar disorder(BD) are still far from being completely understood. Previous evidence has revealed that BD is characterized by glutamate hyperexcitability, suggesting that LiCl may act, at least partially, by toning down glutamatergic signaling abnormalities. OBJECTIVE: In this study, taking advantage of western blot and confocal microscopy, we used a combination of integrative molecular and morphological approaches in rats exposed to repeated administration of LiCl at a therapeutic dose (between 0...
September 13, 2023: Current Neuropharmacology
https://read.qxmd.com/read/37709995/glun2a-mediates-ketamine-induced-rapid-antidepressant-like-responses
#39
JOURNAL ARTICLE
Tonghui Su, Yi Lu, Chaoying Fu, Yang Geng, Yelin Chen
Ketamine was thought to induce rapid antidepressant responses by inhibiting GluN2B-containing N-methyl-D-aspartic acid (NMDA) receptors (NMDARs), which presents a promising opportunity to develop better antidepressants. However, adverse side effects limit the broader application of ketamine and GluN2B inhibitors are yet to be approved for clinical use. It is unclear whether ketamine acts solely through GluN2B-dependent mechanisms. The present study reports that the loss of another major NMDAR subunit, GluN2A, in adult mouse brains elicits robust antidepressant-like responses with limited impact on the behaviors that mimic the psychomimetic effects of ketamine...
September 14, 2023: Nature Neuroscience
https://read.qxmd.com/read/37698384/pharmacological-characterization-of-sage-718-a-novel-nmda-receptor-positive-allosteric-modulator
#40
JOURNAL ARTICLE
Jacob T Beckley, Teresa K Aman, Michael A Ackley, Tatiana M Kazdoba, Michael C Lewis, Anne C Smith, Brandon J Farley, Jing Dai, Wayne Deats, Ethan Hoffmann, Albert J Robichaud, James J Doherty, Michael C Quirk
BACKGROUND AND PURPOSE: Select neuroactive steroids (NAS) tune neural activity by modulating excitatory and inhibitory neurotransmission, including the endogenous cholesterol metabolite 24(S)-hydroxycholesterol (24(S)-HC), which is a N-methyl-d-aspartate receptor (NMDAR) positive allosteric modulator (PAM). NMDAR PAMs are potentially an effective pharmacotherapeutic strategy to treat conditions associated with NMDAR hypofunction. EXPERIMENTAL APPROACHES: Using in vitro and in vivo electrophysiological recording experiments and behavioral approaches, we evaluated the effect of SAGE-718, a novel NAS NMDAR PAM currently in clinical development for the treatment of cognitive impairment, on NMDAR function and endpoints that are altered by NMDAR hypoactivity, and assessed its safety profile...
September 12, 2023: British Journal of Pharmacology
keyword
keyword
118495
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.